Exoskeleton breakthrough: walk Hands-Free after spinal injury?
NCT ID NCT07536386
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new hands-free, self-balancing exoskeleton designed to help people with spinal cord injury walk again. Ten adults with paralysis or weakness in their legs will train with the device over several sessions. The goal is to see if the exoskeleton is safe and helps users complete everyday movements like standing up and walking short distances.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 10 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2026
- Expected to finish
-
Apr 2026
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
User inclusion criteria: * Any gender, age 18 years or older * Motor complete or incomplete SCI at any level * ≥ 6 months post SCI * Able and willing to attend 9 visits to the center, including sessions of training and assessments of one-to-three hours duration * Able to read, understand, and provide informed consent. * Patients affiliated to a social security system. User exclusion criteria: * Diagnosis of neurological injury other than SCI; * Progressive condition that would be expected to result in changing neurological status; * Severe concurrent medical disease, illness or condition judged to be contraindicated by the site physician; * Unhealed or unstable traumatic or high impact lower extremity fracture of any duration that is, in the clinical judgement of the study physician, exclusionary for standing and walking; * Individual with history of osteoporotic fracture and / or pathology or treatment causing secondary osteoporosis. * Untreatable severe spasticity judged to be contraindicated by the site physician; * Untreated/uncontrolled hypertension, as judged to be contraindicated by the site physician; * Unresolved orthostatic hypotension (change from baseline seated BP to a fall in 20mmHg SBP and/or fall in 10mmHG DBP and symptoms when standing), or as judged to be contraindicated by the site physician; * Open or unhealed skin pressure sores, abrasions, or bruises at any of the contact points of the exoskeleton; * Morphological contraindications to the use of the device; * Uncorrectable leg length discrepancy over 2 cm (about 0.79 in) when using additional correction tools; * Unable to effectively operate the device with a controller, due to functional and/or cognitive impairment, evaluated based on the ability to manipulate the joystick in all direction, press and identify buttons on the controller. * Improper fitting in the device; * Psychopathology documentation in the medical record that may conflict with study objectives; * Pregnancy or women who plan to become pregnant during the study period; * Concurrent participation in another interventional trial; * Uncontrolled autonomic dysreflexia; * Ventilator use at the time of the exoskeleton use. * Patient under legal protection. Companion inclusion criteria * Any gender, age 18 years or older. * Willingness to attend 9 to 10 visits to the center, including sessions of training and assessments of one-to-three hours duration with the SCI user. * Able to read, understand and provide informed consent. Companion exclusion criteria: * Inability to communicate due to cognitive and language disorders; * Any disease, concomitant injury, or condition that interferes with the performance or interpretation of the protocol- specified assessments; * Insufficient strength and performance capability, evidenced by the ability to hold and retain the device in case of unbalance/fall; * Insufficient availability to complete the study; * Concurrent participation in another interventional trial.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Paraplegia and tetraplegia are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Wandercraft
RECRUITINGParis, 75004, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Transcutaneous spinal stimulation with intensive physical therapy for locomotion
- Early detrusor chemodenervation to preserve bladder compliance and longevity after spinal cord injury
- Prevention of thromboembolism using apixaban vs enoxaparin following spinal cord injury
- Can a brain implant let paralyzed people control computers with their minds?
- Can ultrasound dye reveal spinal cord damage Mid-Surgery?
- Video diet coaching may cut heart risks after spinal cord injury